Haleon PLC Sponsored ADR (NYSE:HLN) Given Average Rating of “Moderate Buy” by Analysts

Shares of Haleon PLC Sponsored ADR (NYSE:HLN) have earned an average rating of “Moderate Buy” from the ten brokerages that are presently covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $12.3250.

A number of brokerages recently commented on HLN. The Goldman Sachs Group raised Haleon from a “neutral” rating to a “buy” rating in a research note on Wednesday, September 10th. Barclays cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, September 16th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a research report on Wednesday, October 8th.

Haleon Price Performance

Shares of HLN stock opened at $9.81 on Tuesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87. Haleon has a fifty-two week low of $8.71 and a fifty-two week high of $11.42. The firm has a market cap of $43.66 billion, a P/E ratio of 25.14 and a beta of 0.20. The business’s 50 day moving average price is $9.31 and its 200-day moving average price is $9.84.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Brighton Jones LLC purchased a new stake in Haleon in the fourth quarter worth $187,000. Cetera Investment Advisers lifted its position in Haleon by 17.8% during the first quarter. Cetera Investment Advisers now owns 164,390 shares of the company’s stock valued at $1,692,000 after buying an additional 24,876 shares during the period. LPL Financial LLC boosted its holdings in shares of Haleon by 8.3% during the 1st quarter. LPL Financial LLC now owns 1,256,449 shares of the company’s stock valued at $12,929,000 after buying an additional 95,990 shares in the last quarter. PNC Financial Services Group Inc. grew its position in shares of Haleon by 11.7% in the 1st quarter. PNC Financial Services Group Inc. now owns 231,841 shares of the company’s stock worth $2,386,000 after buying an additional 24,373 shares during the period. Finally, Argent Trust Co increased its stake in shares of Haleon by 44.4% in the 1st quarter. Argent Trust Co now owns 43,146 shares of the company’s stock worth $444,000 after acquiring an additional 13,266 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.